FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129468043> ?p ?o ?g. }

• W2129468043 abstract "Protein denitrosylation by thioredoxin reductase (TrxR) is key for maintaining S-nitrosothiol (SNO) homeostasis, although its role in tumor progression is unknown. Therefore, the present study aimed to assess the role of altered SNO homeostasis in breast cancer cells. The impairment of SNO homeostasis in breast cancer cells was achieved with the highly specific TrxR inhibitor auranofin and/or exposure to S-nitroso-L-cysteine. S-nitrosylated proteins were detected using the biotin switch assay. Estrogen receptor (ER) alpha knockdown was achieved using RNA silencing technologies and subcellular localization of ERα was analyzed by confocal microscopy. The Oncomine database was explored for TrxR1 (TXNRD1) expression in breast tumors and TrxR1, ER and p53 expression was analyzed by immunohistochemistry in a panel of breast tumors. The impairment of SNO homeostasis enhanced cell proliferation and survival of ER+ MCF-7 cells, but not of MDA-MB-231 (ER-, mut p53) or BT-474 (ER+, mut p53) cells. This enhanced cell growth and survival was associated with Akt, Erk1/2 phosphorylation, and augmented cyclin D1 expression and was abolished by the ER antagonist fulvestrant or the p53 specific inhibitor pifithrin-α. The specific silencing of ERα expression in MCF-7 cells also abrogated the growth effect of TrxR inhibition. Estrogenic deprivation in MCF-7 cells potentiated the pro-proliferative effect of impaired SNO homeostasis. Moreover, the subcellular distribution of ERα was altered, with a predominant nuclear localization associated with phosphorylation at Thr311 in those cells with impaired SNO homeostasis. The impairment of SNO homeostasis also expanded a cancer stem cell-like subpopulation in MCF-7 cells, as indicated by the increase of percentage of CD44+ cells and the augmented capability to form mammospheres in vitro. Notably, ER+ status in breast tumors was significantly associated with lower TXNDR1 mRNA expression and immunohistochemical studies confirmed this association, particularly when p53 abnormalities were absent. The ER status in breast cancer may dictate tumor response to different nitrosative environments. Impairment of SNO homeostasis confers survival advantages to ER+ breast tumors, and these molecular mechanisms may also participate in the development of resistance against hormonal therapies that arise in this type of mammary tumors." @default.
• W2129468043 created "2016-06-24" @default.
• W2129468043 creator A5020890996 @default.
• W2129468043 creator A5040158829 @default.
• W2129468043 creator A5052857408 @default.
• W2129468043 creator A5055924576 @default.
• W2129468043 creator A5058755562 @default.
• W2129468043 creator A5069741552 @default.
• W2129468043 creator A5074210261 @default.
• W2129468043 creator A5074249583 @default.
• W2129468043 creator A5076562964 @default.
• W2129468043 creator A5089097452 @default.
• W2129468043 date "2012-12-01" @default.
• W2129468043 modified "2023-10-13" @default.
• W2129468043 title "Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors" @default.
• W2129468043 cites W1492951734 @default.
• W2129468043 cites W1978553767 @default.
• W2129468043 cites W1985867072 @default.
• W2129468043 cites W1988734169 @default.
• W2129468043 cites W1989241811 @default.
• W2129468043 cites W1991053809 @default.
• W2129468043 cites W1999438584 @default.
• W2129468043 cites W2004494212 @default.
• W2129468043 cites W2004724154 @default.
• W2129468043 cites W2005563089 @default.
• W2129468043 cites W2014433643 @default.
• W2129468043 cites W2015756677 @default.
• W2129468043 cites W2020131167 @default.
• W2129468043 cites W2023427658 @default.
• W2129468043 cites W2025996212 @default.
• W2129468043 cites W2034001757 @default.
• W2129468043 cites W2038882533 @default.
• W2129468043 cites W2040852689 @default.
• W2129468043 cites W2055393036 @default.
• W2129468043 cites W2068043241 @default.
• W2129468043 cites W2088269939 @default.
• W2129468043 cites W2094420610 @default.
• W2129468043 cites W2097255042 @default.
• W2129468043 cites W2100502993 @default.
• W2129468043 cites W2100821752 @default.
• W2129468043 cites W2107259248 @default.
• W2129468043 cites W2110821710 @default.
• W2129468043 cites W2121155074 @default.
• W2129468043 cites W2122203755 @default.
• W2129468043 cites W2126105922 @default.
• W2129468043 cites W2143004446 @default.
• W2129468043 cites W2147673480 @default.
• W2129468043 cites W2166199264 @default.
• W2129468043 cites W4236203131 @default.
• W2129468043 doi "https://doi.org/10.1186/bcr3366" @default.
• W2129468043 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4053140" @default.
• W2129468043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23216744" @default.
• W2129468043 hasPublicationYear "2012" @default.
• W2129468043 type Work @default.
• W2129468043 sameAs 2129468043 @default.
• W2129468043 citedByCount "22" @default.
• W2129468043 countsByYear W21294680432013 @default.
• W2129468043 countsByYear W21294680432015 @default.
• W2129468043 countsByYear W21294680432016 @default.
• W2129468043 countsByYear W21294680432017 @default.
• W2129468043 countsByYear W21294680432018 @default.
• W2129468043 countsByYear W21294680432019 @default.
• W2129468043 countsByYear W21294680432020 @default.
• W2129468043 countsByYear W21294680432021 @default.
• W2129468043 countsByYear W21294680432022 @default.
• W2129468043 countsByYear W21294680432023 @default.
• W2129468043 crossrefType "journal-article" @default.
• W2129468043 hasAuthorship W2129468043A5020890996 @default.
• W2129468043 hasAuthorship W2129468043A5040158829 @default.
• W2129468043 hasAuthorship W2129468043A5052857408 @default.
• W2129468043 hasAuthorship W2129468043A5055924576 @default.
• W2129468043 hasAuthorship W2129468043A5058755562 @default.
• W2129468043 hasAuthorship W2129468043A5069741552 @default.
• W2129468043 hasAuthorship W2129468043A5074210261 @default.
• W2129468043 hasAuthorship W2129468043A5074249583 @default.
• W2129468043 hasAuthorship W2129468043A5076562964 @default.
• W2129468043 hasAuthorship W2129468043A5089097452 @default.
• W2129468043 hasBestOaLocation W21294680431 @default.
• W2129468043 hasConcept C104317684 @default.
• W2129468043 hasConcept C119056186 @default.
• W2129468043 hasConcept C121608353 @default.
• W2129468043 hasConcept C126322002 @default.
• W2129468043 hasConcept C185592680 @default.
• W2129468043 hasConcept C22615655 @default.
• W2129468043 hasConcept C2780482068 @default.
• W2129468043 hasConcept C502942594 @default.
• W2129468043 hasConcept C530470458 @default.
• W2129468043 hasConcept C54009773 @default.
• W2129468043 hasConcept C54355233 @default.
• W2129468043 hasConcept C55493867 @default.
• W2129468043 hasConcept C62112901 @default.
• W2129468043 hasConcept C63645605 @default.
• W2129468043 hasConcept C71924100 @default.
• W2129468043 hasConcept C81885089 @default.
• W2129468043 hasConcept C84606932 @default.
• W2129468043 hasConcept C86803240 @default.
• W2129468043 hasConcept C95444343 @default.
• W2129468043 hasConceptScore W2129468043C104317684 @default.
• W2129468043 hasConceptScore W2129468043C119056186 @default.
• W2129468043 hasConceptScore W2129468043C121608353 @default.

• next